Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
10/12/1995 | WO1995026754A1 Segmented chelating polymers as imaging and therapeutic agents |
10/12/1995 | WO1995026752A1 Product for the enteric supply of food components and process for making it |
10/12/1995 | WO1995026750A1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix |
10/12/1995 | WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
10/12/1995 | WO1995026720A1 Permanently ionic derivatives of steroid hormones and their antagonists |
10/12/1995 | WO1995026715A2 Use of fatty acid esters as bioadhesive substances |
10/12/1995 | WO1995026713A1 Heterofunctional, mucoadhesive dosage form |
10/12/1995 | WO1995026712A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity |
10/12/1995 | WO1995026711A1 Ophthalmic composition with decreased viscosity |
10/12/1995 | WO1995026709A1 Topical retinal-based composition |
10/12/1995 | WO1995024928A3 Heparin-binding growth factors for gene therapy and anterior eye disorders |
10/12/1995 | WO1995024923A3 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
10/12/1995 | WO1995022991A3 Block copolymers |
10/12/1995 | CA2186863A1 Heterofunctional, mucoadhesive dosage form |
10/12/1995 | CA2186861A1 Biological markers of benign prostate hyperplasia |
10/12/1995 | CA2186734A1 Ophthalmic composition with decreased viscosity |
10/12/1995 | CA2186604A1 Permanently ionic derivatives of steroid hormones and their antagonists |
10/12/1995 | CA2186591A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity |
10/12/1995 | CA2185812A1 Segmented chelating polymers as imaging and therapeutic agents |
10/11/1995 | EP0676470A1 Stem cell factor |
10/11/1995 | EP0676195A1 Cosmetic composition for skin cleansing mask containing polyamide particles of a determined size |
10/11/1995 | EP0676187A2 Composition containing a non photocatalytic metal oxide and tocopherol, its cosmetic and/or dermatologic use and methods for its preparation |
10/11/1995 | EP0675737A1 Immunoreactive reagents employing dihydrofolate reductase |
10/11/1995 | EP0675736A1 Improved synthesis of polymer bio-active conjugates |
10/11/1995 | EP0675734A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT |
10/11/1995 | EP0675727A1 Glycolipid enzyme-polymer conjugates |
10/11/1995 | EP0675711A1 Atovaquone pharmaceutical compositions |
10/11/1995 | EP0559682B1 Topical composition |
10/11/1995 | CN1109891A Methods for preventing degradation of protein C |
10/11/1995 | CN1109886A Method for preparing thioether conjugates |
10/11/1995 | CN1109785A Organopolysiloxane composition of gel-like apperarance, containing no gelling agent, which may be used in cosmetics and dermatology |
10/11/1995 | CN1109756A Calcium-modified oxidized cellulose hemostat |
10/11/1995 | CN1109754A Argatroban consentrated aqueous solution |
10/11/1995 | CN1109751A Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
10/11/1995 | CN1109748A Rapamycin formulation for IV injection |
10/11/1995 | CN1109747A Rapamycin formulation for IV injection |
10/11/1995 | CN1109746A Rapamycin formulations for oral administration |
10/11/1995 | CN1109745A Ibuprofen-containing solid composition |
10/11/1995 | CN1109743A Controlled release-initiation and controlled release-rate pharmaceutical composition |
10/11/1995 | CN1109741A Cosmatic and/or dermal composition containing salicylic acid |
10/10/1995 | US5457195 Sapphyrin derivatives and conjugates |
10/10/1995 | US5457191 3-deazapurines |
10/10/1995 | US5457183 Radiosensitizers |
10/10/1995 | US5457093 Gel formulations containing growth factors |
10/10/1995 | US5456932 Adding fructose to reduce heat needed to create flash flow conditions |
10/10/1995 | US5456925 Salt of ranitidine and complex of bismuth and tartaric or citric acid with alkaline salt; improved disintegration or dissolution |
10/10/1995 | US5456922 Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone |
10/10/1995 | US5456918 Ranitidine pharmaceutical compositions |
10/10/1995 | US5456908 Inhibiting cellular uptake of polyamines by contacting cells with transport inhibitory amount of polymer or copolymer of said polyamines |
10/10/1995 | US5456901 Administering liposome having encapsulated contrast enhancing agent, scanning patient using ultrasonic imaging |
10/10/1995 | US5456663 Drugs and methods for treating diseases |
10/10/1995 | CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
10/10/1995 | CA1337275C Aqueous based pharmaceutical coating composition for dosage forms |
10/10/1995 | CA1337272C Drug adsorbates |
10/10/1995 | CA1337270C Multilayer plaster |
10/10/1995 | CA1337262C Time release protein |
10/05/1995 | WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
10/05/1995 | WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
10/05/1995 | WO1995026200A1 Enhanced virus-mediated dna transfer |
10/05/1995 | WO1995026193A1 Use of hyaluronic acid and forms to prevent arterial restenosis |
10/05/1995 | WO1995026192A1 Starch-metal complexes for skin and hair |
10/05/1995 | WO1995026191A1 Injectable solutions of dirithromycin |
10/05/1995 | DE4411402A1 DNA-Expressionsvektoren zur Verwendung in der gentherapeutischen Behandlung von Gefäßerkrankungen DNA expression vectors for use in gene therapy of vascular diseases |
10/05/1995 | CA2186448A1 Starch-metal complexes for skin and hair |
10/05/1995 | CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf) |
10/04/1995 | EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
10/04/1995 | EP0674907A2 Conjugabes of a antibody and a carrier protein, useful for active immunotherapy |
10/04/1995 | EP0674901A1 Transdermal matrix system comprising a styrene-isoprene-styrene copolymer for the administration of an oestrogen and/or gestagen |
10/04/1995 | EP0674900A1 Transdermal matrix system comprising EVA for the administration of an oestrogen and/or gestagen |
10/04/1995 | EP0674734A1 Runway-maintenance device. |
10/04/1995 | EP0674646A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
10/04/1995 | EP0674531A1 Process for preparing a virus-safe biological composition |
10/04/1995 | EP0674529A1 Lipid prodrugs for oral administration |
10/04/1995 | EP0674528A1 Cyclodextrin and polymer based drug delivery system |
10/04/1995 | EP0674525A1 Aqueous pharmaceutical preparations of g-csf with a long shelf life |
10/04/1995 | EP0674524A1 Stable lyophilized pharmaceutical preparations g-csf |
10/04/1995 | EP0674522A1 Linseed mucilage |
10/04/1995 | EP0674510A1 Injectable composition |
10/04/1995 | EP0674507A1 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
10/04/1995 | EP0674506A1 Controlled release growth hormone containing microspheres |
10/04/1995 | EP0674505A1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails |
10/04/1995 | EP0592446B1 Loading technique for preparing drug containing liposomes |
10/04/1995 | CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates |
10/04/1995 | CN1109364A Insulin formulation |
10/04/1995 | CN1109328A Sustained release formulations for 24 hour release of metoprolol |
10/04/1995 | CN1109289A Method for making selenium garlic capsule |
10/03/1995 | US5455335 Glycosylated steroids |
10/03/1995 | US5455286 Bioactive composition |
10/03/1995 | US5455270 Stabilized solutions of platinum(II) antitumor agents |
10/03/1995 | US5455236 Stable aqueous compositions |
10/03/1995 | US5455168 α-glycosyl trehalose-forming enzyme |
10/03/1995 | US5455158 Imaging fibrin-containing substance using labeled polypeptide imaging agent which binds to fibrin |
10/03/1995 | US5455046 Includes a heteropolysaccharide gum and a homopolysaccharide gum capable of crosslinking |
10/03/1995 | US5455045 High dose formulations |
10/03/1995 | US5455042 Ointment comprising a homogenous mixture of a polymer or copolymer of N-vinylacetamide, water and/or alcohols, and a pharmacologically active component |
10/03/1995 | US5455037 Erythromycin cream |
10/03/1995 | US5455032 Use of phosphocholine hapten conjugates in vaccines |
10/03/1995 | US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method |
10/03/1995 | US5455027 Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
09/29/1995 | CA2145584A1 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |